Logo

BD Biosciences Wins Patent On Gene Cloning System

Jun 28, 2002

NEW YORK, June 28-BD Biosciences has been granted a U.S. patent for its high-throughput gene cloning system, the company said yesterday.

 

The company's BD Creator system transfers genes into expression vectors without requiring subcloning or restriction enzymes. Applications of the technology include studies of protein-protein interactions, gene expression patterns and functional genomics.

 

The United States Patent and Trade Office granted the patent to BD's Clontech division on June 25.

 

BD Biosciences, a division of BD, produces lab products and services.

Breaking News
The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.